Last updated on January 2019

A Study of Molidustat for Correction of Renal Anemia in Non-dialysis Subjects

Brief description of study

The purpose of this study is to evaluate the efficacy and safety of molidustat in non-dialysis subjects with renal anemia who are not treated with Erythropoiesis-Stimulating Agents (ESAs).

Clinical Study Identifier: NCT03350321

Contact Investigators or Research Sites near you

Start Over

Bayer Clinical Trials Contact

Iizuka Hospital
Iizuka, Japan

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.